Skip to content

Repetitive transcranial magnetic stimulation and constraint-induced therapy for hemiplegic cerebral palsy: a multicenter clinical trial

Repetitive transcranial magnetic stimulation and constraint-induced therapy for hemiplegic cerebral palsy: a multicenter clinical trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021924
Enrollment
Unknown
Registered
2019-03-16
Start date
2019-03-30
Completion date
Unknown
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegic cerebral palsy

Interventions

1:CIMT+rTMS sham
2:CIMT+rTMS
blank control:CIMT

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Diagnostic and classification criteria for hemiplegic cerebral palsy; (2) Aged 2-15 years old; (3) MACSI-III; (4) From the full flexion position, the wrist joint extension is =20 degrees, and the metacarpophalangeal joint is =10 degrees; (5) The difference between the scores of the overall evaluation scale of the hand and the hand function is 20%-80%; (6) Have a certain cognitive ability, can understand simple instructions, parents can cooperate with research and sign consent.

Exclusion criteria

Exclusion criteria: (1) suffering from other diseases not related to cerebral palsy; (2) Fixed contracture or deformity affecting the functional use of the hand; (3) severe hemiplegia (manual ability classification system IV or V or <20 degree finger/wrist extension) or major dystonia; (4) Children with epilepsy or severe sensory or visual problems; (5) TMS contraindications; (6) taking a drug that reduces muscle tone within 3 months before treatment, has received botulinum toxin injection in the last 6 months, or is ready to receive botulinum toxin type A during the study period; Received CIMT in the past 6 months; (7) The upper limb of the affected side has undergone orthopedic surgery.

Design outcomes

Primary

MeasureTime frame
The Melbourne Assessment 2;MT?MEP?Amplitude and latency,CMCT;(Motion threshold, motion evoked potential amplitude and latency, central conduction time);

Secondary

MeasureTime frame
SCUES;Nine hole test;MAS;AROM;Infant - junior high school students social life ability scale;GAS,Goal Attainment Scale;fMRI?DTI;

Countries

China

Contacts

Public ContactQian-Wen WU

Guangzhou Women and Children's Medical Center

492470130@qq.com+86 13544505511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026